Articles

Podcasts

Videos

Clinical

After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.

Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients

HIV epidemics are emerging among key populations in the Middle East and North Africa, and the region ranks lowest globally in response indicators. 

Middle East, North Africa Face Emerging HIV Epidemics With Lagging Response

Investigators found potentially infectious monkeypox virus DNA in saliva and semen.

Identifying Monkeypox Viral DNA in Bodily Fluid Samples

Visceral leishmaniasis patients coinfected with HIV are vulnerable to other comorbidities including tuberculosis and cryptococcal meningitis but also to degrees of stigmatization and human rights issues. 

New Treatment for HIV, Visceral Leishmaniasis Coinfection

A positive recommendation now heads to the European Commission, which can grant marketing authorization for 27 European Union member states. 

EMA Moves Forward with Recommendation for Lenacapavir based on 26-Week Data

Dr. Arlene Sena and her team are working to develop a syphilis vaccine, “But we need to know what’s circulating worldwide first.”

Utilizing Global Surveillance to Develop a Syphilis Vaccine

The commitment to ending the HIV epidemic endures, despite drops in testing and new diagnoses during the COVID-19 pandemic. 

HIV Testing and Diagnoses Drop During COVID-19 Pandemic 

“It’s time to ensure widespread availability by promoting access to safe, effective, and sustainably priced medications, rather than providing incentives to prescribe higher-cost alternatives,” the authors said. 

An Unintended Consequence for High HIV Drug Prices 

Joined by Steven Wolfe, DO, MPH, and Stuart A Fisk, CRNP, of the Allegheny Health Network, we discuss the populations most at risk of HIV infection, as well as advice for making healthcare spaces more inclusive and accessible for LGBTQ+ people.

Episode 5: “A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People

Findings highlight need for innovative prevention strategies, experts say.

SEXUALLY TRANSMITTED DISEASES

Latest News